Compare QNCX & MDV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | QNCX | MDV |
|---|---|---|
| Founded | 2012 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Transportation Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 139.2M | 149.6M |
| IPO Year | 2019 | 2022 |
| Metric | QNCX | MDV |
|---|---|---|
| Price | $3.80 | $14.89 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $7.75 | N/A |
| AVG Volume (30 Days) | ★ 1.1M | 33.9K |
| Earning Date | 11-12-2025 | 11-14-2025 |
| Dividend Yield | N/A | ★ 7.86% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $47,479,000.00 |
| Revenue This Year | N/A | $0.13 |
| Revenue Next Year | N/A | $0.71 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.72 | $13.62 |
| 52 Week High | $4.55 | $17.15 |
| Indicator | QNCX | MDV |
|---|---|---|
| Relative Strength Index (RSI) | 64.26 | 58.71 |
| Support Level | $3.74 | $14.50 |
| Resistance Level | $4.55 | $15.10 |
| Average True Range (ATR) | 0.46 | 0.32 |
| MACD | 0.05 | 0.04 |
| Stochastic Oscillator | 64.39 | 76.00 |
Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics. Company pipeline includes Ataxia-Telangiectasia(EryDex), Duchenne Muscular Dystrophy, New Indications and Program Expansion Potential.
Modiv Industrial Inc is a pioneer in the direct-to-consumer commercial real estate product industry. It provides individual investors access to real estate and real estate-related investments designed to provide both income and long-term growth. The Company has invested in single-tenant income-producing properties. Its current business consists of owning, managing, operating, leasing, acquiring, investing in and disposing of commercial real estate assets utilized for industrial manufacturing, as well as a few non-core assets. All of the company's consolidated revenues are derived from company's consolidated real estate properties.